Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380091447> ?p ?o ?g. }
- W4380091447 endingPage "117367" @default.
- W4380091447 startingPage "117367" @default.
- W4380091447 abstract "Despite considerable recent progress in therapeutic strategies, cancer still remains one of the leading causes of death. Molecularly targeted therapies, in particular those focused on blocking receptor tyrosine kinases have produced promising outcomes in recent years. In this study, a new series of spiro[indoline-3,2'-quinazoline]-2,4'(3'H)-dione derivatives (5a-5l) were synthesized and evaluated as potential kinase inhibitors with anticancereffects. The anti-proliferative activity was measured by MTT assay, while the cell cycle was studied using flow cytometry. Moreover, kinase inhibition profiles of the most promising compounds were assessed against a panel of 25 oncogenic kinases. Compounds 5f,5g,5i, and 5jshowed anti-proliferative effect against EBC-1, A549, and HT-29 solid tumor models in addition to leukemia cell line K562. In particular, compound 5f, bearing 4-methylphenyl pendant on the isatin ring displayed considerable potency with IC50 values of 2.4 to 13.4 μM against cancer cells. The most potent derivatives also altered the distribution of cells in different phases of cell cycle and increased the sub-G1 phase cells in K562 cells. Moreover, kinase inhibition assays identified FLT3 kinase was as the primary targetof these derivatives. Compound 5f at 25 μM concentration showed inhibitory activities of 55% and 62% against wild-type FLT3 and its mutant, D835Y, respectively. Finally, the docking and simulation studies revealed the important interactions of compound 5f with wild type and mutant FLT3. The results of this study showed that some novel spiroindoline quinazolinedione compounds could be potential candidates for further development as novel targeted anticancer agents." @default.
- W4380091447 created "2023-06-10" @default.
- W4380091447 creator A5005759043 @default.
- W4380091447 creator A5019027440 @default.
- W4380091447 creator A5022910316 @default.
- W4380091447 creator A5023364723 @default.
- W4380091447 creator A5024571867 @default.
- W4380091447 creator A5032620524 @default.
- W4380091447 creator A5065222117 @default.
- W4380091447 creator A5067246937 @default.
- W4380091447 creator A5070732129 @default.
- W4380091447 creator A5091349162 @default.
- W4380091447 date "2023-07-01" @default.
- W4380091447 modified "2023-09-27" @default.
- W4380091447 title "Novel spiroindoline quinazolinedione derivatives as anticancer agents and potential FLT3 kinase inhibitors" @default.
- W4380091447 cites W1991053537 @default.
- W4380091447 cites W1993560396 @default.
- W4380091447 cites W2000771161 @default.
- W4380091447 cites W2028160054 @default.
- W4380091447 cites W2036208429 @default.
- W4380091447 cites W2042382807 @default.
- W4380091447 cites W2045683699 @default.
- W4380091447 cites W2050456292 @default.
- W4380091447 cites W2087023176 @default.
- W4380091447 cites W2102185636 @default.
- W4380091447 cites W2121691961 @default.
- W4380091447 cites W2126075231 @default.
- W4380091447 cites W2132629607 @default.
- W4380091447 cites W2138884392 @default.
- W4380091447 cites W2169678694 @default.
- W4380091447 cites W2188886527 @default.
- W4380091447 cites W2301031844 @default.
- W4380091447 cites W2469514391 @default.
- W4380091447 cites W2557896003 @default.
- W4380091447 cites W2617492002 @default.
- W4380091447 cites W2756912518 @default.
- W4380091447 cites W2772644783 @default.
- W4380091447 cites W2791996570 @default.
- W4380091447 cites W2797193450 @default.
- W4380091447 cites W2888462768 @default.
- W4380091447 cites W2902063722 @default.
- W4380091447 cites W2949236218 @default.
- W4380091447 cites W2950083367 @default.
- W4380091447 cites W2975481196 @default.
- W4380091447 cites W3009629639 @default.
- W4380091447 cites W3020813431 @default.
- W4380091447 cites W3049022240 @default.
- W4380091447 cites W3102781337 @default.
- W4380091447 cites W3119123076 @default.
- W4380091447 cites W3126070941 @default.
- W4380091447 cites W3128646645 @default.
- W4380091447 cites W3134719153 @default.
- W4380091447 cites W3155849694 @default.
- W4380091447 cites W3161074857 @default.
- W4380091447 cites W3164370300 @default.
- W4380091447 cites W3164835888 @default.
- W4380091447 cites W3173381592 @default.
- W4380091447 cites W3205666384 @default.
- W4380091447 cites W4210342503 @default.
- W4380091447 cites W4221023876 @default.
- W4380091447 cites W4224990395 @default.
- W4380091447 cites W4296129731 @default.
- W4380091447 cites W4309184823 @default.
- W4380091447 doi "https://doi.org/10.1016/j.bmc.2023.117367" @default.
- W4380091447 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37348260" @default.
- W4380091447 hasPublicationYear "2023" @default.
- W4380091447 type Work @default.
- W4380091447 citedByCount "0" @default.
- W4380091447 crossrefType "journal-article" @default.
- W4380091447 hasAuthorship W4380091447A5005759043 @default.
- W4380091447 hasAuthorship W4380091447A5019027440 @default.
- W4380091447 hasAuthorship W4380091447A5022910316 @default.
- W4380091447 hasAuthorship W4380091447A5023364723 @default.
- W4380091447 hasAuthorship W4380091447A5024571867 @default.
- W4380091447 hasAuthorship W4380091447A5032620524 @default.
- W4380091447 hasAuthorship W4380091447A5065222117 @default.
- W4380091447 hasAuthorship W4380091447A5067246937 @default.
- W4380091447 hasAuthorship W4380091447A5070732129 @default.
- W4380091447 hasAuthorship W4380091447A5091349162 @default.
- W4380091447 hasConcept C1491633281 @default.
- W4380091447 hasConcept C178790620 @default.
- W4380091447 hasConcept C184235292 @default.
- W4380091447 hasConcept C185592680 @default.
- W4380091447 hasConcept C2777256644 @default.
- W4380091447 hasConcept C2778866207 @default.
- W4380091447 hasConcept C2780783641 @default.
- W4380091447 hasConcept C29537977 @default.
- W4380091447 hasConcept C54355233 @default.
- W4380091447 hasConcept C55493867 @default.
- W4380091447 hasConcept C62112901 @default.
- W4380091447 hasConcept C71240020 @default.
- W4380091447 hasConcept C81885089 @default.
- W4380091447 hasConcept C86803240 @default.
- W4380091447 hasConceptScore W4380091447C1491633281 @default.
- W4380091447 hasConceptScore W4380091447C178790620 @default.
- W4380091447 hasConceptScore W4380091447C184235292 @default.
- W4380091447 hasConceptScore W4380091447C185592680 @default.
- W4380091447 hasConceptScore W4380091447C2777256644 @default.